Health Canada drug identification number

DIN 02501600 — INQOVI 100 MG; 35 MG

INQOVI is a tablet of Cedazuridine / Decitabine marketed by TAIHO PHARMA CANADA, INC.. The full Cedazuridine / Decitabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02501600
Brand name
INQOVI
Active ingredient
Cedazuridine / Decitabine
Strength
100 MG; 35 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
TAIHO PHARMA CANADA, INC.
Health Canada status
MARKETED
Drug class
Antineoplastic agent (hypomethylating agent / cytidine deaminase inhibitor combination)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.